Williams, Michelle C
Golay, Saroj K
Hunter, Amanda
Weir-McCall, Jonathan R
Mlynska, Lucja
Dweck, Marc R
Uren, Neal G
Reid, John H
Lewis, Steff C
Berry, Colin
van Beek, Edwin J R
Roditi, Giles
Newby, David E
Mirsadraee, Saeed
Clinical trials referenced in this document:
Documents that mention this clinical trial
CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial
https://doi.org/10.1016/s0140-6736(15)60291-4
Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
https://doi.org/10.1136/heartjnl-2017-311508
Cardiovascular health technology assessment: recommendations to improve the quality of evidence
https://doi.org/10.1136/openhrt-2018-000930
Evaluation of coronary artery disease as a risk factor for reticular pseudodrusen
https://doi.org/10.1136/bjophthalmol-2017-310526
Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial
https://doi.org/10.1136/openhrt-2014-000234
Clinical determinants of plasma cardiac biomarkers in patients with stable chest pain (Post-results)
https://doi.org/10.1136/heartjnl-2019-314892
Machine learning to predict high-risk coronary artery disease on CT in the SCOT-HEART trial
https://doi.org/10.1136/openhrt-2025-003162